Guest column

How the pandemic advanced tech in government and education, according to this Houston expert

As we overcome the COVID crisis, and look to rebuild our economy and overcome future challenges, we need to learn from this experience and refuse to go back to the bad old days of red tape and stale technology. Photo via Getty Images

If you've logged onto a government website recently, you know that dealing with creaking, outdated government technology is about as much fun as a trip to the DMV. Held back by byzantine procurement rules, management-by-committee, and an aggressive commitment to decades-old UX principles, government websites and other tech tools are routinely confusing, horrible to use, and deeply inefficient.

Now, though, that could finally be changing. The COVID-19 pandemic has forced us all to rethink our relationships with the technologies we use, from Zoom calls to e-commerce services. Increasingly, government bodies are finding themselves forced to move faster, adopt more up-to-date technologies, and work with private-sector partners to meet new challenges and quickly bring their services into the 21st century.

Getting an education

One of the most dramatic examples comes in the realm of education. According to the U.S. Census Bureau, about 93 percent of school-age children have engaged in distance learning since the pandemic began, and four fifths of them relied on digital tech to take the place of classroom resources. But with access to digital tech at home strongly correlated to household income, governments and education departments have had to move quickly to ensure every child has access to laptops and web connections.

Not everyone is a fan of remote learning, and as a parent myself, I know how hard it can be to have kids at home. But one thing we should all be able to agree on is that if we're going to rely on digital learning, then we need to make sure it's available to everyone, including those families that don't have access to reliable computers and WiFi connections at home.

Achieving that rapidly and at scale has required remarkable flexibility and creativity from policymakers at all levels. Those that have succeeded have done so by brushing aside the red tape that has ensnared previous government tech initiatives, and instead working with private-sector partners to rapidly implement the solutions that are needed.

Lessons from Texas

Here in Texas, for instance, one in six public school students lacked access to high-speed internet connections at the start of the pandemic, and 30% lacked access to laptops or other learning devices. To speed the transition to remote learning, Gov. Greg Abbott and the Texas Education Agency (TEA) launched Operation Connectivity — a $400 million campaign to connect 5.5 million Texas public school students with a computer device and reliable internet connection. To date 4 million devices have been purchased and are being distributed to kids, opening doors to greater educational and economic opportunities. Further work is in progress to remove other connectivity barriers like slow connection speeds in rural areas to help students and all Texans.

Rolling out such an ambitious project to our state's 1,200 or so school districts could have been a disaster. After all, many government IT projects grind along for months or years without delivering the desired results — often at huge cost to taxpayers. But Operation Connectivity has been different because it's grounded in a true partnership between the government and private-sector players.

Facing urgent deadlines, government leaders turned to Gaby Rowe, former CEO of the Ion tech hub, to spearhead the project. As a tech innovator, Rowe brought entrepreneurial energy and a real understanding of the power of public-private partnerships, and drove Operation Connectivity from the blueprint to execution in a matter of weeks. Tech giants including Microsoft, SAP, and Hubspot also quickly joined the effort, helping to deliver cost-effective connectivity and hardware solutions to ensure that every kid in our state could get the education they deserve. Since then, Operation Connectivity has distributed over a million devices, including laptops and wireless hotspots, to families in need, with costs split between the state and individual districts.

Private sector edge

To get a sense of how private-sector knowhow can spur government tech transformation, consider my own company, Digital Glyde. As part of the Operation Connectivity effort, we were asked to help design and build the back-end software and planning infrastructure needed to coordinate effectively with hundreds of school district officials scattered all across our state.

Ordinarily, that kind of effort would require a drawn-out process of consultation, committee-work, and red tape. But facing an urgent need to help our state's children, we were given the freedom to move quickly, and were able to implement a viable system within just a few days.

By leveraging cutting-edge data-extraction and image-processing tools, we helped Operation Connectivity to automatically process invoices and match tech costs to available COVID relief funding in record time. We achieved 95% accuracy within three weeks of deployment to ensure school districts quickly received reimbursements for the hardware they were purchasing on behalf of their schoolchildren.

Building on success

Operation Connectivity is just one example of the ways in which government actors have embraced tech and leveraged private-sector assistance to chart their way through the COVID crisis. From contact-tracing programs to vaccine distribution programs, we're seeing governments taking a far more pragmatic and partnership-driven approach to technology.

Of course, not every experiment goes to plan. In Florida, government agencies decided to use web tools to manage vaccination appointments — but implemented that idea using a commercial website built to handle birthday party e-vites. Unsurprisingly, the results were chaotic, with users having to scramble to grab appointments as they were posted to the site, and seniors struggling to wrap their head around a website designed for young parents.

Such stories are a reminder that governments can't solve big problems simply by grabbing at whatever tech tools are nearest to hand. It's vital to find the right solutions, and to work with partners who understand the complexity and constraints that come with delivering public-sector services at scale.

As we overcome the COVID crisis, and look to rebuild our economy and overcome future challenges, we need to learn from this experience and refuse to go back to the bad old days of red tape and stale technology. In recent months, we've shown what can be done when we pull together, and combine real governmental leadership with private-sector innovation and efficiency. We'll need much more of this kind of teamwork and tech-enabled creativity in the months and years to come.

------

Varun Garg is the founder and CEO of Houston-based Digital Glyde

Trending News

Building Houston

 
 

The Texas Medical Center Innovation Factory has named the 16 companies making up the inaugural cohort in the Innovate UK Global Incubator Programme. Photo via tmc.edu

Sixteen digital health and medical device startups founded in the United Kingdom have been selected for a customized accelerator at the Texas Medical Center's Innovation Factory.

In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.

“The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries," says Ashley McPhail, chief external affairs and administration officer for TMC, in a news release. "We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator."

The 16 companies will participate in the program from June to November. The cohort is expected to arrive in Houston on June 5 and have access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US. The new offering joins three other globally recognized curriculums: Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

“TMCi nurtures long-term growth, development, and competitiveness to increase startups chances of success and global expansion," says Emily Reiser, associate director of TMC Innovation. "By bringing their novel technologies and exposing them to a curated selection of TMC’s expert network, startups receive support and evaluation to build, scale, and expand in the US market."

Two of the cohort's specialties include cardiovascular and oncology — two of TMC's strongest areas of expertise — with solutions ranging from surgical devices to AI-enabled risk stratification and hospital efficiency.

Innovate UK is the country's national innovation agency dedicated to supporting business-led innovation in all sectors.

“The United Kingdom is fully committed to improving global healthcare through scientific collaboration," says His Majesty’s Consul General in Texas Richard Hyde in the release. "Through the expansion of the TMC UK BioBridge and in partnership with Innovate UK, this programme will help to expose the brightest and best British companies to the world’s largest medical city. Our companies will collaborate and grow as they work to develop cutting edge technology. The partnership between the UK Government and TMC demonstrates that international collaboration can drive both economic growth and improvement to quality of life.”

The 16 companies making up the inaugural cohort are as follows, according to TMC.

  • AINOSTICS aims to revolutionize the treatment and prevention of neurological conditions, such as dementia, by developing innovative AI-enabled solutions that draw novel insights from routinely acquired non-invasive medical scans to deliver accurate diagnosis and outcome prediction, and in turn facilitate personalized care and timely access to disease-modifying treatments for patients.
  • Alvie is a blended human plus AI-enabled digital solution providing personalised pre and rehabilitation coaching and supportive care for cancer and surgery. Alvie's technology combines data profiling, risk-stratification and tailored prescriptions of health and well-being with curated educational content, targeted behaviour change coaching and expert support through chat messaging and virtual consultations.
  • C the Signs™ is a validated AI cancer prediction platform, which can identify patients at risk of cancer at the earliest and most curable stage of the disease. Used by healthcare professionals, C the Signs can identify which tumor type a patient is at risk of and recommend the most appropriate next step in less than 30 seconds. The platform has detected over 10,000 patients with cancer, with over 50 different types of cancer diagnosed, and with a sensitivity of >98% for cancer.
  • At PEP Health, We believe all patients deserve the best care possible. Our cutting-edge machine-learning technology enables healthcare organisations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
  • PreciousMD improves the lives of lung-cancer and other lung-related illnesses patients worldwide by enabling imaging-based diagnostics needed for personalized treatment pathways.
  • Ufonia is an autonomous telemedicine company, we use large language models and voice AI to increase the capacity of clinical professionals.
  • My mhealth offers digital therapeutics for a range of long-term conditions- COPD, Asthma, Diabetes and Heart Disease. Our product has been successfully deployed in the UK and India, with >100,000 users registered to date. Our solutions empower patients to self-manage their conditions, resulting in dramatic improvements in outcomes, as evidenced through multiple clinical trials and real-world evaluations.
  • At Surgery Hero, we offer a clinically backed solution that ensures whole-human support before and after surgery. We help health systems, employers and health plans cut costs without sacrificing quality of care.
  • Panakeia's software platform enables extremely rapid multi-omics profiling in minutes directly from routinely used tissue images without needing wet lab assays.
  • QV Bioelectronics are striving to deliver longer, better quality lives for brain tumour patients. Using their first-of-its-kind implantable electric field therapy device, GRACE, QV will provide effective, focal & continuous treatment without impacting patient quality of life.
  • 52 North is a med-tech company focused on improving health outcomes and health equity by reinventing care pathways. The NeutroCheck® solution is a finger-prick blood test and digital platform built to significantly improve safety and quality of life for cancer patients, by helping to identify at-home those patients who are at risk of the most fatal side-effect of chemotherapy: neutropenic sepsis.
  • Somnus is fulfilling an unmet need in global healthcare by developing real-time, point of care blood propofol monitoring. Its products will improve the care of sedated and anaesthetised patients, save money for hospitals, and facilitate a major reduction in greenhouse gas emissions.
  • ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for cost-efficient and longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs.
  • IBEX is on a mission to help people live active, healthy and productive lives by increasing their access to early diagnosis of osteoporosis. The IBEX BH software as medical device delvers routine, automated assessment of fracture risk from routine radiology for earlier detection and more equitable treatment of osteoporosis.
  • NuVision produces products derived from donated human amniotic membrane that are used in ophthalmology to help patients with chronic, traumatic and post-surgical wounds of the eye to be treated earlier and recover more fully and more quickly. The company’s products are also used in the management of dry eye disease, a debilitating conditions that affects around 17m people in the USA.
  • Calon Cardio-Technology is on a mission to improve quality of life for patients with Left Ventricular Assist devices (LVAD) and reduce the common post operative complications associated with these implantable heart pumps. We plan to do this by introducing a completely wireless heart pump system and augment patient follow-up with built-in remote monitoring capabilities.

Trending News